Description
MEDICINE REQUIRED FOR CLINICAL TRIAL 551 FOR THE CSP
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-09-30+$1,050,168= $1,050,168
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-09-30 | +$1,050,168 | $1,050,168 | MEDICINE REQUIRED FOR CLINICAL TRIAL 551 FOR THE CSP |
Related awards · 8
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D92HARF1LKA9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA501D00015 | 501 - ALBUQUERQUE · 6505 · DRUGS AND BIOLOGICALS | $186,366 | FY2010 |
| VA673P00603 | 673-TAMPA · 6505 · DRUGS AND BIOLOGICALS | $6,880 | FY2010 |
| V797P5878X | DEPT OF VETERANS AFFAIRS · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2010 |
Other recipients under 6505 from 501 - ALBUQUERQUE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA5011P3170 | DXE MEDICAL, INC. | 501 - ALBUQUERQUE | $3,300 | FY2011 |
| VA501Q10649 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 501 - ALBUQUERQUE | $8,258 | FY2011 |
| V501PPVFY10AUG | MCKESSON CORPORATION | 501 - ALBUQUERQUE | $1,329,655 | FY2010 |
| V501PPVFY10JUL | MCKESSON CORPORATION | 501 - ALBUQUERQUE | $1,145,243 | FY2010 |
| V501PPVFY10JUN | MCKESSON CORPORATION | 501 - ALBUQUERQUE | $1,371,400 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA501D90035_3600_V797P5878X_3600 · retrieved 2026-09-26.